IRIS
ROTI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.891
AS - Asia 5.318
EU - Europa 3.743
SA - Sud America 727
AF - Africa 275
Continente sconosciuto - Info sul continente non disponibili 205
OC - Oceania 9
Totale 16.168
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.706
SG - Singapore 1.839
CN - Cina 1.346
IT - Italia 1.254
VN - Vietnam 874
BR - Brasile 544
IE - Irlanda 491
HK - Hong Kong 416
SE - Svezia 366
DE - Germania 344
BD - Bangladesh 255
FR - Francia 244
FI - Finlandia 189
NL - Olanda 188
ZA - Sudafrica 170
UA - Ucraina 153
GB - Regno Unito 128
IN - India 115
TR - Turchia 112
CA - Canada 107
RU - Federazione Russa 107
AT - Austria 102
AR - Argentina 69
JP - Giappone 49
IQ - Iraq 44
MX - Messico 41
PH - Filippine 38
PL - Polonia 33
KR - Corea 32
CI - Costa d'Avorio 31
EC - Ecuador 29
ES - Italia 27
BE - Belgio 25
PK - Pakistan 25
ID - Indonesia 24
CO - Colombia 23
TH - Thailandia 20
VE - Venezuela 19
UZ - Uzbekistan 18
CZ - Repubblica Ceca 17
LT - Lituania 16
EG - Egitto 13
TW - Taiwan 13
IR - Iran 12
PY - Paraguay 12
SA - Arabia Saudita 12
TN - Tunisia 12
CL - Cile 11
KE - Kenya 11
MA - Marocco 11
JM - Giamaica 10
UY - Uruguay 10
DZ - Algeria 9
AU - Australia 8
NP - Nepal 8
AZ - Azerbaigian 7
IL - Israele 7
JO - Giordania 7
KZ - Kazakistan 7
PA - Panama 7
RO - Romania 7
CR - Costa Rica 6
PE - Perù 6
CH - Svizzera 5
ET - Etiopia 5
HU - Ungheria 5
KG - Kirghizistan 5
LU - Lussemburgo 5
MY - Malesia 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
GR - Grecia 4
HR - Croazia 4
LB - Libano 4
OM - Oman 4
SY - Repubblica araba siriana 4
AL - Albania 3
DO - Repubblica Dominicana 3
MD - Moldavia 3
NI - Nicaragua 3
PT - Portogallo 3
SC - Seychelles 3
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
DK - Danimarca 2
KH - Cambogia 2
KW - Kuwait 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
Totale 15.947
Salva come PNG Salva come JPEG
Città #
Singapore 953
Ashburn 772
San Jose 616
Dallas 491
Dublin 491
Chandler 472
Hong Kong 394
Parma 313
Santa Clara 311
Beijing 297
Council Bluffs 263
Ho Chi Minh City 258
Boardman 241
Hanoi 195
Johannesburg 160
Jacksonville 136
Ann Arbor 126
Los Angeles 125
Lauterbourg 124
New York 123
Dearborn 107
Milan 106
Munich 100
Princeton 90
Vienna 86
Nanjing 85
Shanghai 81
Bologna 76
Izmir 72
Hefei 70
Wilmington 62
Helsinki 56
Buffalo 55
São Paulo 55
Grafing 53
Shenyang 51
San Mateo 50
Marseille 49
Rome 49
Jinan 44
Toronto 44
Nanchang 43
Moscow 42
Chicago 41
Haiphong 39
Columbus 37
Da Nang 37
Seattle 37
Montreal 33
Turku 33
Hebei 32
Abidjan 31
Amsterdam 29
Tokyo 29
Frankfurt am Main 28
Guangzhou 28
Reggio Emilia 27
Modena 26
Tianjin 26
Verona 26
Changsha 25
Nuremberg 25
London 24
Brescia 23
The Dalles 23
Atlanta 22
Des Moines 22
Kunming 22
Phoenix 22
Seoul 22
Warsaw 22
Brooklyn 21
Brussels 21
Houston 21
Rio de Janeiro 21
Denver 20
Pune 20
Baghdad 19
Poplar 19
Bremen 17
Fremont 17
Orem 17
Hải Dương 16
Jiaxing 16
Brasília 15
Florence 15
Jakarta 15
San Francisco 15
Tashkent 15
Turin 15
Bengaluru 14
Biên Hòa 14
Mexico City 14
Perugia 14
West Jordan 14
Naples 13
Norwalk 13
Zhengzhou 13
Belo Horizonte 12
Brno 12
Totale 9.646
Salva come PNG Salva come JPEG
Nome #
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line 263
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 262
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 247
Morphological, clinical, and molecular profiling of post-polycythemia vera accelerated/blast phase occurring with and without antecedent secondary myelofibrosis 234
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 230
1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients 220
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 215
Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non–Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors 205
227P Sexual dimorphism in immune profile of early and advanced NSCLC 204
Impact of the rs1024611 polymorphism of ccl2 on the pathophysiology and outcome of primary myelofibrosis 193
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 190
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 189
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 188
Targeting oncogenic Notch signaling with SERCA inhibitors 188
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 179
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients 176
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 175
Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia 174
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 171
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 167
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 161
Angiopoietins expression by human myeloma cells 161
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 159
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 159
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 156
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 154
Venetoclax and bortezomib in relapsed/refractory early t-cell precursor acute lymphoblastic leukemia 153
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes 152
Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns acquired resistance to immunotherapy in patients with NSCLC 151
IL-7 is induced by IL-6 in human myeloma cells: role in multiple myeloma 150
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 149
Targeting Notch Trafficking and Processing in Cancers 149
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 148
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 148
Acute lymphoblastic leukaemia in Noonan syndrome. 146
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 144
14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia 143
Acute lymphoblastic leukaemia 141
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 139
SERCA MODULATION COUNTERACTS GLUCOCORTICOID RESISTANCE IN T-ALL 137
THERAPEUTIC TARGETING OF NOTCH SIGNALING PATHWAY IN HEMATOLOGICAL MALIGNANCIES 137
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 136
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520 135
MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia 134
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 133
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 133
Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia 133
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 132
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia 131
CD26 is differentially expressed throughout the life cycle of infantile hemangiomas and characterizes the proliferative phase 131
A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome 130
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro 129
Down-Modulation of Erk Protein Kinase Activity Inhibits Vascular Endothelial Growth Factor (VEGF) Secretion by human Myeloma Cell Lines 126
Activating somatic and germline TERT promoter variants in myeloid malignancies 125
Haploidentical hematopoietic stem cell transplantation in adults using the αβTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cells 125
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia 123
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 121
VASCULAR ENDOTHELIAL GROWTH FACTOR SECRETION BY MYELOMA CELLS IS INHIBITED BY DOWN-MODULATING ERK PROTEIN KINASE ACTIVITY 120
Osteopontin is produced by human multiple myeloma cells 120
IL-7 is produced by myeloma cells in presence of IL-6 119
Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic Leukemia 118
Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling 117
Down-modulation of ERK protein kinase activity suppresses human myeloma cell proliferation and myeloma-induced angiogenesis by VEGF inhibition 116
Multiple myeloma patient with unusual extramedullary involvement 115
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 114
Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia. 114
A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromes 110
Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia 109
Multiple Myeloma patient with unusual extramedullary involvement 109
Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma 109
WO/2016/073708 109
Multiple myeloma patient with unusual extramedullary involvement 109
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 108
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines 108
Bilateral tonsillar infiltration of T-cell prolymphocytic leukemia 108
Chemical Genomic Screen Identifies Ionophores as Modulators of Notch1 in T-ALL 108
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 107
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 106
Genetic and proteomic approaches to identify cancer drug targets. 105
Bone marrow endothelial cells carry BCR/ABL fusion gene from chronic myeloid leukemia patients. 105
IL-7 is produced by myeloma cells in presence of IL-6 104
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION 102
Leukemia-specific delivery of mutant NOT CH1 targeted therapy 102
Human myeloma cells express IL-7 mRNA and secrete IL-7 in presence of IL-6 101
Synergistic drug combinations with a CDK4/6 inhibitor in T-cell acute lymphoblastic leukemia 101
FROM GENOMICS TO CHEMOGEGNOMICS IN T CELL ACUTE LYMPHOBLASTIC LEUKEMIA 99
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin 97
Genetic profile of acute lymphoblastic leukemia in a patient with the noonan syndrome 96
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: From current standards to precision medicine 95
Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer. 93
Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors. 92
Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy with Thyroid Carcinoma Cells: Novel Translational Insights 90
e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia 88
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 88
Differentially regulated high-throughput CT imaging features correlate to distinct tumor immune contextures portraying a radiomic signature with prognostic impact on surgically resected NSCLC 88
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia. 87
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study 86
New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma 86
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines. 86
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma 85
Totale 13.713
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.309
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022501 0 16 11 15 7 64 72 55 27 40 32 162
2022/20231.922 219 191 106 124 206 206 32 117 585 7 82 47
2023/2024987 50 64 29 41 85 184 124 80 40 72 72 146
2024/20253.056 90 164 215 235 337 246 145 137 350 251 275 611
2025/20267.339 582 537 1.006 669 936 440 688 322 976 585 356 242
2026/2027586 284 302 0 0 0 0 0 0 0 0 0 0
Totale 16.168